DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 173 filers reported holding DENALI THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,529,000 | +322.1% | 115,000 | +342.3% | 0.69% | +214.7% |
| Q1 2022 | $836,000 | -81.3% | 26,000 | -74.0% | 0.22% | -82.3% |
| Q4 2021 | $4,460,000 | +17.9% | 100,000 | +33.3% | 1.23% | +13.4% |
| Q3 2021 | $3,784,000 | -40.4% | 75,000 | -7.4% | 1.09% | -37.8% |
| Q2 2021 | $6,354,000 | +14.7% | 81,000 | -16.5% | 1.75% | +10.5% |
| Q1 2021 | $5,539,000 | +15.0% | 97,000 | +68.7% | 1.58% | +10.5% |
| Q4 2020 | $4,816,000 | -18.5% | 57,500 | -65.2% | 1.43% | -20.8% |
| Q3 2020 | $5,912,000 | +88.1% | 165,000 | +26.9% | 1.81% | +92.1% |
| Q2 2020 | $3,143,000 | +99.4% | 130,000 | +44.4% | 0.94% | +35.6% |
| Q1 2020 | $1,576,000 | – | 90,000 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $298,165,000 | 48.02% |
| Bratton Capital Management, L.P. | 953,035 | $14,600,000 | 28.53% |
| Flagship Pioneering Inc. | 8,005,747 | $122,648,000 | 6.71% |
| Casdin Capital, LLC | 650,000 | $9,958,000,000 | 1.03% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $67,568,000 | 0.50% |
| MARK ASSET MANAGEMENT LP | 68,864 | $1,055,000 | 0.26% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 22,507 | $345,000 | 0.26% |
| Artal Group S.A. | 400,000 | $6,128,000 | 0.25% |
| PIER 88 INVESTMENT PARTNERS LLC | 40,610 | $622,000 | 0.24% |
| HAMILTON LANE ADVISORS LLC | 30,948 | $474,000 | 0.20% |